课题基金 / 基金详情

Laboratory Core-A Regional Reference Laboratory for LF Elimination

Laboratory Core-A Regional Reference Laboratory for LF Elimination
核心实验室-消除低频区域参考实验室
批准号:
7805582
负责人:
Hanan Helmy
金额:
$2.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2013-04-30

项目摘要

项目成果

Hanan Helmy的其他基金

相似基金

相关文献

中文摘要
翻译
核心B型LF消除参比实验室
英文摘要
Core B Reference Laboratory for LF Elimination This scientific core aims to establish a reference laboratory at Ain Shams University in Egypt for monitoring filariasis elimination programs. This will be a prototype for a network of regional reference laboratories that will have high throughput capability for parasite DNA detection and antibody testing to service monitoring needs of LF elimination programs in countries and regions. The Core will serve both Projects in the ICIDR. The Core is necessary for the large number of samples that will be collected in ICIDR. Project I, and it will also serve the needs of Project 2 (new tool development). We will upgrade laboratory capabilities with new instrumentation and training. The Core will receive, process, and archive samples. It will perform assays and report results to the Data Management Core and Project scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Laboratory Core-A Regional Reference Laboratory for LF Elimination
  • 批准号:
    6973743
  • 项目类别:
  • 资助金额:
    $5.9万
  • 财政年份:
    2005
  • 负责人:
    Hanan Helmy
  • 依托单位:
Laboratory Core-A Regional Reference Laboratory for LF Elimination
  • 批准号:
    7549260
  • 项目类别:
  • 资助金额:
    $7.66万
  • 财政年份:
    --
  • 负责人:
    Hanan Helmy
  • 依托单位:
Laboratory Core-A Regional Reference Laboratory for LF Elimination
  • 批准号:
    7549266
  • 项目类别:
  • 资助金额:
    $4.59万
  • 财政年份:
    --
  • 负责人:
    Hanan Helmy
  • 依托单位:
Laboratory Core-A Regional Reference Laboratory for LF Elimination
  • 批准号:
    7626435
  • 项目类别:
  • 资助金额:
    $2.45万
  • 财政年份:
    --
  • 负责人:
    Hanan Helmy
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究